Rivian Stock Surges After Third-Quarter Revenue Report

Rivian stock surged after results showed revenue growth and a return to positive gross margins, triggering heavy options activity and volatile trading.

November 10, 2025·2 min read
View all news articles
Minimalist flat-vector Rivian on a graphite-frost smooth gradient background evoking Rivian stock revenue and margins.

KEY TAKEAWAYS

  • Q3 revenue was $1.6 billion, up 78.0% year-over-year.
  • The company returned to positive gross margins, posting $24 million gross profit.
  • Large-volume call-option buying had followed the report, adding to volatile trading.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Rivian stock jumped in volatile trading after the automaker’s Nov. 4 Q3 2025 report showed sharp revenue growth and a return to positive gross margins, while traders intensified options activity, MarketBeat reported on Nov. 10.

Q3 Results and Market Response

Rivian Automotive reported Q3 2025 revenue of $1.6 billion, up 78.0% year-over-year, providing fresh context for its narrowed delivery guidance. The company returned to positive gross margins, posting a gross profit of $24 million, driven by growth in both vehicle sales and software and services.

The automaker produced 10,720 vehicles and delivered 13,201 in the quarter, compared with 13,157 produced and 10,018 delivered in Q3 2024. This delivery mix helped lift revenue despite ongoing investments in manufacturing scale.

Software and service revenue surged 324.0% year-over-year to $416 million, with about half coming from the Volkswagen joint venture. These recurring revenue streams now represent roughly 26.0% of total sales, highlighting a shift in Rivian’s revenue mix as vehicle volumes grow.

Adjusted EBITDA loss narrowed to $602 million from $757 million a year earlier. Management described the improvement as consistent with progress toward longer-term profitability while maintaining investment in growth.

Following the earnings release, MarketBeat reported large-volume call-option buying, reflecting heightened speculative interest and heavier short-term trading flows. This surge in options activity tracked the quarter’s revenue and margin improvements and contributed to volatile sessions after the report. Rivian’s market capitalization stood at $20.03 billion as of Nov. 10.

Guidance and Strategic Outlook

Rivian narrowed its 2025 full-year delivery forecast to 41,500–43,500 units and maintained adjusted EBITDA loss guidance at $2.0–$2.25 billion. The company targets EBITDA breakeven in 2027.

Management outlined the timeline for the lower-priced R2 SUV, aiming to begin validation manufacturing by year-end 2025, with sales planned for the first half of 2026 and a production ramp in the second half. A new factory in Georgia is expected online in late 2028, with capacity for about 400,000 vehicles annually. This facility is central to Rivian’s plans for long-term scale and cost reduction.

The company flagged headwinds including the expiration of certain federal electric-vehicle tax credits for 2026 and lingering tariffs adding a few hundred dollars per vehicle.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

U.S.-Switzerland Trade Deal Lowers Tariffs

U.S.-Switzerland trade deal eases pressure on Swiss watch and pharmaceutical exporters and reduces a near-term sales and pricing headwind for traders.

Ron Baron Tesla Sees $2,500 Target, Holds Stakes

Ron Baron Tesla reaffirmed a lifetime hold and backed Musk's pay package, spotlighting governance and focusing investors on his $2,500 Tesla price target.

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.